{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:52:15Z","timestamp":1793674335287,"version":"4.5.1"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015569","name":"Consortium canadien en neurod\u00e9g\u00e9n\u00e9rescence associ\u00e9e au vieillissement","doi-asserted-by":"publisher","award":["031168"],"award-info":[{"award-number":["031168"]}],"id":[{"id":"10.13039\/100015569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005247","name":"The University of British Columbia","doi-asserted-by":"publisher","award":["6456"],"award-info":[{"award-number":["6456"]}],"id":[{"id":"10.13039\/501100005247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Health Research BC","doi-asserted-by":"publisher","award":["16353"],"award-info":[{"award-number":["16353"]}],"id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.clinbiochem.2026.111093","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:25:00Z","timestamp":1769819100000},"page":"111093","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["\u03b1-Synuclein seed amplification assay methodology and performance in Parkinson\u2019s disease, lewy body dementia, and multiple system atrophy: A meta-analysis"],"prefix":"10.1016","volume":"142","author":[{"given":"Cyril","family":"Helbling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9281-9547","authenticated-orcid":false,"given":"Mari L.","family":"DeMarco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2026.111093_b0005","doi-asserted-by":"crossref","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson's disease. Lancet 2021;397:10291:2284-303. Epub 20210410 doi: 10.1016\/S0140-6736(21)00218-X.","DOI":"10.1016\/S0140-6736(21)00218-X"},{"key":"10.1016\/j.clinbiochem.2026.111093_b0010","first-page":"181","article-title":"Phenotypic heterogeneity in dementia: a challenge for epidemiology and biomarker studies. Front","volume":"6","author":"Ryan","year":"2018","journal-title":"Public Health"},{"issue":"5","key":"10.1016\/j.clinbiochem.2026.111093_b0015","first-page":"61","article-title":"The differential diagnosis and treatment of atypical parkinsonism","volume":"113","author":"Levin","year":"2016","journal-title":"Dtsch. Arztebl. Int."},{"issue":"6","key":"10.1016\/j.clinbiochem.2026.111093_b0020","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1212\/WNL.0000000000002350","article-title":"Accuracy of clinical diagnosis of parkinson disease: a systematic review and meta-analysis","volume":"86","author":"Rizzo","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.clinbiochem.2026.111093_b0025","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/jnnp-2017-316844","article-title":"Accuracy of clinical diagnosis of dementia with lewy bodies: a systematic review and meta-analysis","volume":"89","author":"Rizzo","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.clinbiochem.2026.111093_b0030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10286-021-00782-w","article-title":"Limitations of the unified multiple system atrophy rating scale as outcome measure for clinical trials and a roadmap for improvement","volume":"31","author":"Palma","year":"2021","journal-title":"Clin. Auton. Res."},{"issue":"12","key":"10.1016\/j.clinbiochem.2026.111093_b0035","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"Mds clinical diagnostic criteria for parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.clinbiochem.2026.111093_b0040","unstructured":"Crotty GF, O'Corragain O, Bogue CO, Crotty J, O'Sullivan SS. The utility of dopamine transporter scans for diagnosing parkinsonian disorders. 2018."},{"key":"10.1016\/j.clinbiochem.2026.111093_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/biom12040576","article-title":"Rt-quic and related assays for detecting and quantifying prion-like pathological seeds of \u03b1-synuclein","volume":"12","author":"Srivastava","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.clinbiochem.2026.111093_b0050","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-021-00501-z","article-title":"Neuropathology and molecular diagnosis of synucleinopathies","volume":"16","author":"Koga","year":"2021","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111093_b0055","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1373\/jalm.2019.029801","article-title":"In vitro conversion assays diagnostic for neurodegenerative proteinopathies","volume":"5","author":"Singh","year":"2020","journal-title":"The Journal of Applied Laboratory Medicine"},{"issue":"2","key":"10.1016\/j.clinbiochem.2026.111093_b0060","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1021\/acschemneuro.8b00383","article-title":"Alpha-synuclein in peripheral tissues in parkinson\u2019s disease","volume":"10","author":"Ma","year":"2019","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.clinbiochem.2026.111093_b0065","doi-asserted-by":"crossref","unstructured":"Canaslan S, Schmitz M, Maass F, Hermann P, da Silva Correia S, Zhang S, et al. Detection of alpha synuclein seeding activity in tear fluid in patients with parkinson\u2019s disease. bioRxiv 2025:2025.01.16.633314 doi: 10.1101\/2025.01.16.633314.","DOI":"10.1101\/2025.01.16.633314"},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111093_b0070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/mds.29246","article-title":"Salivary \u03b1-synuclein rt-quic correlates with disease severity in de novo parkinson's disease","volume":"38","author":"Vivacqua","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.clinbiochem.2026.111093_b0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011456","article-title":"\u0391-synuclein seeding activity in duodenum biopsies from parkinson's disease patients","volume":"19","author":"Vascellari","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.clinbiochem.2026.111093_b0080","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.parkreldis.2022.08.012","article-title":"In vivo and autopsy validation of alpha-synuclein seeding activity using rt-quic assay in the gastrointestinal tract of patients with parkinson's disease","volume":"103","author":"Shin","year":"2022","journal-title":"Parkinsonism Relat. Disord."},{"issue":"6","key":"10.1016\/j.clinbiochem.2026.111093_b0085","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/s41591-023-02358-9","article-title":"Propagative \u03b1-synuclein seeds as serum biomarkers for synucleinopathies","volume":"29","author":"Okuzumi","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.clinbiochem.2026.111093_b0090","doi-asserted-by":"crossref","first-page":"1 :24","DOI":"10.1186\/s40035-019-0164-x","article-title":"Efficient rt-quic seeding activity for \u03b1-synuclein in olfactory mucosa samples of patients with parkinson\u2019s disease and multiple system atrophy","volume":"8","author":"De Luca","year":"2019","journal-title":"Translational Neurodegeneration"},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111093_b0095","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jamaneurol.2020.3311","article-title":"Skin \u03b1-synuclein aggregation seeding activity as a novel biomarker for parkinson disease","volume":"78","author":"Wang","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.clinbiochem.2026.111093_b0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.parkreldis.2022.05.006","article-title":"Combined csf \u03b1-syn rt-quic, csf nfl and midbrain-pons planimetry in degenerative parkinsonisms: from bedside to bench, and back again","volume":"99","author":"Compta","year":"2022","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.clinbiochem.2026.111093_b0105","article-title":"Prisma 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.clinbiochem.2026.111093_b0110","article-title":"Graphpad prism 10.6.1. San Diego","author":"Inc","year":"2023","journal-title":"CA"},{"key":"10.1016\/j.clinbiochem.2026.111093_b0115","series-title":"Jmp\u00ae, version 17 pro","author":"Inc","year":"2023"},{"issue":"8","key":"10.1016\/j.clinbiochem.2026.111093_b0120","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"Quadas-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann. Intern. Med."},{"issue":"10","key":"10.1016\/j.clinbiochem.2026.111093_b0125","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/acn3.338","article-title":"Alpha\u2010synuclein rt\u2010quic in the csf of patients with alpha\u2010synucleinopathies","volume":"3","author":"Fairfoul","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"4","key":"10.1016\/j.clinbiochem.2026.111093_b0130","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/brain\/awab005","article-title":"Alpha-synuclein seeds in olfactory mucosa of patients with isolated rem sleep behaviour disorder","volume":"144","author":"Stefani","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.clinbiochem.2026.111093_b0135","doi-asserted-by":"crossref","first-page":"1 :62","DOI":"10.1186\/s40478-021-01175-w","article-title":"Streamlined alpha-synuclein rt-quic assay for various biospecimens in parkinson\u2019s disease and dementia with lewy bodies","volume":"9","author":"Bargar","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111093_b0140","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00401-020-02160-8","article-title":"Ultrasensitive rt-quic assay with high sensitivity and specificity for lewy body-associated synucleinopathies","volume":"140","author":"Rossi","year":"2020","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2026.111093_b0145","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/ana.25447","article-title":"\u0391-synuclein real-time quaking-induced conversion in the cerebrospinal fluid of uncertain cases of parkinsonism","volume":"85","author":"Van Rumund","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clinbiochem.2026.111093_b0150","doi-asserted-by":"crossref","first-page":"1 :7","DOI":"10.1186\/s40478-018-0508-2","article-title":"Rapid and ultra-sensitive quantitation of disease-associated \u03b1-synuclein seeds in brain and cerebrospinal fluid by \u03b1syn rt-quic","volume":"6","author":"Groveman","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"issue":"20","key":"10.1016\/j.clinbiochem.2026.111093_b0155","doi-asserted-by":"crossref","first-page":"e2513","DOI":"10.1212\/WNL.0000000000011935","article-title":"In vivo diagnosis of synucleinopathies: a comparative study of skin biopsy and rt-quic","volume":"96","author":"Donadio","year":"2021","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.clinbiochem.2026.111093_b0160","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/mds.28912","article-title":"Combining skin \u03b1-synuclein real-time quaking-induced conversion and circulating neurofilament light chain to distinguish multiple system atrophy and parkinson\u2019s disease","volume":"37","author":"Martinez-Valbuena","year":"2022","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111093_b0165","first-page":"1","article-title":"Neurofilament light chain and \u03b1-synuclein rt-quic as differential diagnostic biomarkers in parkinsonisms and related syndromes","volume":"7","author":"Quadalti","year":"2021","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.clinbiochem.2026.111093_b0170","article-title":"Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with lewy bodies. Brain","volume":"3","author":"Perra","year":"2021","journal-title":"Communications"},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111093_b0175","first-page":"1","article-title":"Diagnostic value of skin rt-quic in parkinson\u2019s disease: a two-laboratory study","volume":"7","author":"Kuzkina","year":"2021","journal-title":"npj Parkinson's Dis."},{"issue":"2","key":"10.1016\/j.clinbiochem.2026.111093_b0180","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/brain\/awab431","article-title":"Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies","volume":"145","author":"Poggiolini","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.clinbiochem.2026.111093_b0185","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-021-01276-6","article-title":"Association between csf alpha-synuclein seeding activity and genetic status in parkinson\u2019s disease and dementia with lewy bodies","volume":"9","author":"Brockmann","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"issue":"9","key":"10.1016\/j.clinbiochem.2026.111093_b0190","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/mds.28651","article-title":"Rt-quic detection of pathological \u03b1-synuclein in skin punches of patients with lewy body disease","volume":"36","author":"Mammana","year":"2021","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.clinbiochem.2026.111093_b0195","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/acn3.51280","article-title":"A rapid \u03b1-synuclein seed assay of parkinson's disease csf panel shows high diagnostic accuracy","volume":"8","author":"Orr\u00f9","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"6","key":"10.1016\/j.clinbiochem.2026.111093_b0200","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/acn3.772","article-title":"Group tBLS. \u0391-synuclein rt-quic in cerebrospinal fluid of lrrk2-linked parkinson's disease","volume":"6","author":"Garrido","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"3","key":"10.1016\/j.clinbiochem.2026.111093_b0205","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11481-019-09835-4","article-title":"Ultrasensitive detection of aggregated \u03b1-synuclein in glial cells, human cerebrospinal fluid, and brain tissue using the rt-quic assay: New high-throughput neuroimmune biomarker assay for parkinsonian disorders","volume":"14","author":"Manne","year":"2019","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.clinbiochem.2026.111093_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-021-00491-y","article-title":"Discrimination of msa-p and msa-c by rt-quic analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories","volume":"16","author":"Bargar","year":"2021","journal-title":"Mol. Neurodegener."},{"issue":"4","key":"10.1016\/j.clinbiochem.2026.111093_b0215","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/mds.27646","article-title":"Comparative study of cerebrospinal fluid \u03b1\u2010synuclein seeding aggregation assays for diagnosis of parkinson's disease","volume":"34","author":"Kang","year":"2019","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.clinbiochem.2026.111093_b0220","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/mds.27907","article-title":"\u0391-synuclein real-time quaking-induced conversion in the submandibular glands of parkinson's disease patients","volume":"35","author":"Manne","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.clinbiochem.2026.111093_b0225","article-title":"High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early parkinson\u2019s disease","volume":"9","author":"Russo","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.clinbiochem.2026.111093_b0230","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cca.2022.02.006","article-title":"\u0391-synuclein in parkinson's disease and advances in detection","volume":"529","author":"Chen","year":"2022","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2026.111093_b0235","first-page":"1 :37","article-title":"Olfactory swab sampling optimization for \u03b1-synuclein aggregate detection in patients with parkinson\u2019s disease","volume":"11","author":"Bongianni","year":"2022","journal-title":"Translational Neurodegeneration"},{"issue":"6","key":"10.1016\/j.clinbiochem.2026.111093_b0240","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/mds.29340","article-title":"Dermal real-time quaking-induced conversion is a sensitive marker to confirm isolated rapid eye movement sleep behavior disorder as an early \u03b1-synucleinopathy","volume":"38","author":"Kuzkina","year":"2023","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"2","key":"10.1016\/j.clinbiochem.2026.111093_b0245","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/mds.29284","article-title":"Brain and cerebrospinal fluid \u03b1-synuclein real-time quaking-induced conversion identifies lewy body pathology in lrrk2-pd","volume":"38","author":"Garrido","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.clinbiochem.2026.111093_b0250","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-022-01093-6","article-title":"Diagnostic value of plasma p-tau181, nfl, and gfap in a clinical setting cohort of prevalent neurodegenerative dementias","volume":"14","author":"Baiardi","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.clinbiochem.2026.111093_b0255","doi-asserted-by":"crossref","unstructured":"Giannini G, Baiardi S, Dellavalle S, Zenesini C, Cevoli S, Danner N, et al. In vivo assessment of lewy body and beta-amyloid copathologies in idiopathic normal pressure hydrocephalus: Prevalence and associations with clinical features and surgery outcome. Fluids and Barriers of the CNS 2022;19:1:71 doi: 10.1186\/s12987-022-00368-2.","DOI":"10.1186\/s12987-022-00368-2"},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111093_b0260","first-page":"1","article-title":"Linking the phenotype of snca triplication with pet-mri imaging pattern and alpha-synuclein csf seeding","volume":"8","author":"Wurster","year":"2022","journal-title":"npj Parkinson's Dis."},{"issue":"4","key":"10.1016\/j.clinbiochem.2026.111093_b0265","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/mds.29329","article-title":"Accurate detection of \u03b1-synuclein seeds in cerebrospinal fluid from isolated rapid eye movement sleep behavior disorder and patients with parkinson's disease in the denovo parkinson (denopa) cohort","volume":"38","author":"Concha-Marambio","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.clinbiochem.2026.111093_b0270","doi-asserted-by":"crossref","first-page":"1 :90","DOI":"10.1186\/s40478-022-01388-7","article-title":"Performance of \u03b1synuclein rt-quic in relation to neuropathological staging of lewy body disease","volume":"10","author":"Hall","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"issue":"10","key":"10.1016\/j.clinbiochem.2026.111093_b0275","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1002\/mds.28715","article-title":"Seed amplification assay to diagnose early parkinson's and predict dopaminergic deficit progression","volume":"36","author":"Concha-Marambio","year":"2021","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.clinbiochem.2026.111093_b0280","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/acn3.51753","article-title":"Central and peripheral \u03b1\u2010synuclein in parkinson disease detected by seed amplification assay","volume":"10","author":"Chahine","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2026.111093_b0285","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","article-title":"Assessment of heterogeneity among participants in the parkinson's progression markers initiative cohort using \u03b1-synuclein seed amplification: a cross-sectional study","volume":"22","author":"Siderowf","year":"2023","journal-title":"The Lancet Neurology"},{"issue":"5","key":"10.1016\/j.clinbiochem.2026.111093_b0290","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3233\/JPD-230065","article-title":"Seed amplification assay as a diagnostic tool in newly-diagnosed parkinson's disease","volume":"13","author":"Oftedal","year":"2023","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.clinbiochem.2026.111093_b0295","first-page":"1 :79","article-title":"Combining skin and olfactory \u03b1-synuclein seed amplification assays (saa)-towards biomarker-driven phenotyping in synucleinopathies","volume":"9","author":"Kuzkina","year":"2023","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.clinbiochem.2026.111093_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2023.105807","article-title":"\u0391-synuclein seed amplification assay as a diagnostic tool for parkinsonian disorders","volume":"117","author":"Fernandes Gomes","year":"2023","journal-title":"Parkinsonism Relat. Disord."},{"issue":"12","key":"10.1016\/j.clinbiochem.2026.111093_b0305","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1007\/s00415-023-11810-2","article-title":"Seed amplification assay results illustrate discrepancy in parkinson's disease clinical diagnostic accuracy and error rates","volume":"270","author":"Middleton","year":"2023","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2026.111093_b0310","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/acn3.52034","article-title":"Multiple biomarkers improve diagnostic accuracy across lewy body and alzheimer's disease spectra","volume":"11","author":"Plastini","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"4","key":"10.1016\/j.clinbiochem.2026.111093_b0315","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1002\/alz.13658","article-title":"Investigating alpha-synuclein co-pathology in alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay","volume":"20","author":"Bellomo","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"2","key":"10.1016\/j.clinbiochem.2026.111093_b0320","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jamaneurol.2016.4547","article-title":"Development of a biochemical diagnosis of parkinson disease by detection of \u03b1-synuclein misfolded aggregates in cerebrospinal fluid","volume":"74","author":"Shahnawaz","year":"2017","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.clinbiochem.2026.111093_b0325","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/nan.12524","article-title":"Baseline concentration of misfolded \u03b1-synuclein aggregates in cerebrospinal fluid predicts risk of cognitive decline in parkinson's disease","volume":"45","author":"Ning","year":"2019","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"7794","key":"10.1016\/j.clinbiochem.2026.111093_b0330","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","article-title":"Discriminating \u03b1-synuclein strains in parkinson\u2019s disease and multiple system atrophy","volume":"578","author":"Shahnawaz","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.clinbiochem.2026.111093_b0335","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ana.25824","article-title":"Alpha-synuclein oligomers and neurofilament light chain in spinal fluid differentiate multiple system atrophy from lewy body synucleinopathies","volume":"88","author":"Singer","year":"2020","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.clinbiochem.2026.111093_b0340","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/acn3.50897","article-title":"\u0391-synuclein rt-quic assay in cerebrospinal fluid of patients with dementia with lewy bodies","volume":"6","author":"Bongianni","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.clinbiochem.2026.111093_b0345","article-title":"Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies","author":"Poggiolini","year":"2021","journal-title":"Brain - A Journal of Neurology"},{"key":"10.1016\/j.clinbiochem.2026.111093_b0350","doi-asserted-by":"crossref","first-page":"1 :18","DOI":"10.1007\/s00401-023-02663-0","article-title":"Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to lewy body disease stage and pathology burden","volume":"147","author":"Bentivenga","year":"2024","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111093_b0355","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s40001-024-01705-x","article-title":"Detection of skin \u03b1-synuclein using rt-quic as a diagnostic biomarker for parkinson's disease in the chinese population","volume":"29","author":"Li","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.clinbiochem.2026.111093_b0360","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209656","article-title":"Association of csf \u03b1-synuclein seeding amplification assay results with clinical features of possible and probable dementia with lewy bodies","volume":"103","author":"Coughlin","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.clinbiochem.2026.111093_b0365","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-024-01565-x","article-title":"Clinical, neuropathological, and molecular characteristics of rapidly progressive dementia with lewy bodies: a distinct clinicopathological entity?","volume":"16","author":"Bentivenga","year":"2024","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.clinbiochem.2026.111093_b0370","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-024-00789-w","article-title":"Neuronal alpha-synuclein disease integrated staging system performance in ppmi, pasadena, and spark baseline cohorts","volume":"10","author":"Dam","year":"2024","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.clinbiochem.2026.111093_b0375","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-024-00806-y","article-title":"\u0391-synuclein seed amplification assay sensitivity may be associated with cardiac mibg abnormality among patients with lewy body disease","volume":"10","author":"Kurihara","year":"2024","journal-title":"NPJ Parkinsons Dis"},{"issue":"12","key":"10.1016\/j.clinbiochem.2026.111093_b0380","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S1474-4422(24)00395-8","article-title":"Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort study","volume":"23","author":"Ma","year":"2024","journal-title":"The Lancet Neurology"},{"issue":"8","key":"10.1016\/j.clinbiochem.2026.111093_b0385","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/mds.29828","article-title":"Detection of \u03b1-synuclein in oral mucosa by seed amplification assay in synucleinopathies and isolated rem sleep behavior disorder","volume":"39","author":"Zheng","year":"2024","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.clinbiochem.2026.111093_b0390","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/mds.28242","article-title":"Blinded rt-quic analysis of \u03b1-synuclein biomarker in skin tissue from parkinson's disease patients","volume":"35","author":"Manne","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.clinbiochem.2026.111093_b0395","first-page":"1 :87","article-title":"The alpha-synuclein rt-quic products generated by the olfactory mucosa of patients with parkinson\u2019s disease and multiple system atrophy induce inflammatory responses in sh-sy5y cells","volume":"11","author":"De Luca","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.clinbiochem.2026.111093_b0400","article-title":"Application of \u03b1-syn real-time quaking-induced conversion for brain and skin specimens of the chinese patients with parkinson's disease","volume":"14","author":"Chen","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"9","key":"10.1016\/j.clinbiochem.2026.111093_b0405","doi-asserted-by":"crossref","first-page":"e930","DOI":"10.1212\/WNL.0000000000012438","article-title":"Diagnostic value of the csf \u03b1-synuclein real-time quaking-induced conversion assay at the prodromal mci stage of dementia with lewy bodies","volume":"97","author":"Rossi","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.clinbiochem.2026.111093_b0410","article-title":"A skin-specific \u03b1-synuclein seeding amplification assay for diagnosing parkinson\u2019s disease","volume":"10","author":"Kuang","year":"2024","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.clinbiochem.2026.111093_b0415","doi-asserted-by":"crossref","first-page":"1 :35","DOI":"10.1186\/s40035-024-00426-9","article-title":"Ultrasensitive detection of aggregated \u03b1-synuclein using quiescent seed amplification assay for the diagnosis of parkinson\u2019s disease","volume":"13","author":"Mao","year":"2024","journal-title":"Translational Neurodegeneration"},{"issue":"3","key":"10.1016\/j.clinbiochem.2026.111093_b0420","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.bbrc.2008.01.140","article-title":"Sequence determinants regulating fibrillation of human \u03b1-synuclein","volume":"368","author":"Koo","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.clinbiochem.2026.111093_b0425","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1373\/clinchem.2015.246280","article-title":"Stard 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"61","author":"Bossuyt","year":"2015","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/j.clinbiochem.2026.111093_b0430","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3390\/biomedicines10030599","article-title":"Heterogeneity of multiple system atrophy: an update","volume":"10","author":"Jellinger","year":"2022","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.clinbiochem.2026.111093_b0435","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.neulet.2009.12.027","article-title":"Clinical availability of skin biopsy in the diagnosis of parkinson's disease","volume":"469","author":"Miki","year":"2010","journal-title":"Neurosci. Lett."},{"issue":"10","key":"10.1016\/j.clinbiochem.2026.111093_b0440","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/NEN.0b013e318186de48","article-title":"Lewy body pathology involves cutaneous nerves","volume":"67","author":"Ikemura","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2026.111093_b0445","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ana.21291","article-title":"Association of olfactory dysfunction with risk for future parkinson's disease","volume":"63","author":"Ross","year":"2008","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.clinbiochem.2026.111093_b0450","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1097\/NEN.0b013e31818b4126","article-title":"Incidence and extent of lewy body-related \u03b1-synucleinopathy in aging human olfactory bulb","volume":"67","author":"Sengoku","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.clinbiochem.2026.111093_b0455","doi-asserted-by":"crossref","DOI":"10.1016\/0140-6736(92)93275-R","article-title":"Preliminary diagnosis of parkinson's disease by olfactory bulb pathology","volume":"340","author":"Daniel","year":"1992","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.clinbiochem.2026.111093_b0460","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/neup.12205","article-title":"Neuropathologic assessment of participants in two multi-center longitudinal observational studies: the alzheimer disease neuroimaging initiative (adni) and the dominantly inherited alzheimer network (dian)","volume":"35","author":"Cairns","year":"2015","journal-title":"Neuropathology"},{"key":"10.1016\/j.clinbiochem.2026.111093_b0465","article-title":"Incidence of parkinson disease in north america","volume":"8","author":"Willis","year":"2022","journal-title":"npj Parkinson's Dis."},{"issue":"5","key":"10.1016\/j.clinbiochem.2026.111093_b0470","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.neurol.2023.11.013","article-title":"Prevalence of multiple system atrophy: a literature review","volume":"180","author":"Kaplan","year":"2024","journal-title":"Rev. Neurol. (Paris)"},{"issue":"7","key":"10.1016\/j.clinbiochem.2026.111093_b0475","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1080\/03007995.2022.2059978","article-title":"Epidemiology and economic burden of lewy body dementia in the united states","volume":"38","author":"Desai","year":"2022","journal-title":"Curr. Med. Res. Opin."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111093_b0480","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1590\/1516-3180.2020.0119.r1.30102020","article-title":"Descriptive epidemiological study on patients with movement disorders, with emphasis on parkinson's disease","volume":"139","author":"Balestrassi","year":"2021","journal-title":"Sao Paulo Med J"},{"issue":"4","key":"10.1016\/j.clinbiochem.2026.111093_b0485","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/mds.870060412","article-title":"Profile of patients enrolled in a new movement disorder clinic","volume":"6","author":"Siemers","year":"1991","journal-title":"Mov. Disord."},{"issue":"Suppl 1","key":"10.1016\/j.clinbiochem.2026.111093_b0490","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1017\/cjn.2016.2","article-title":"The prevalence and incidence of dementia with lewy bodies: a systematic review","volume":"43","author":"Hogan","year":"2016","journal-title":"Can. J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.clinbiochem.2026.111093_b0495","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1176\/jnp.13.3.374","article-title":"Comparison of extrapyramidal signs in dementia with lewy bodies and parkinson's disease","volume":"13","author":"Aarsland","year":"2001","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111093_b0500","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13195-020-00684-5","article-title":"Differential diagnostic value of total alpha-synuclein assay in the cerebrospinal fluid between alzheimer's disease and dementia with lewy bodies from the prodromal stage","volume":"12","author":"Bousiges","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.clinbiochem.2026.111093_b0505","doi-asserted-by":"crossref","DOI":"10.1002\/alz.13762","article-title":"Blood tests for alzheimer's disease: the impact of disease prevalence on test performance","author":"DeMarco","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/j.clinbiochem.2026.111093_b0510","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1474-4422(20)30449-X","article-title":"Detection of \u03b1-synuclein in csf by rt-quic in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study","volume":"20","author":"Iranzo","year":"2021","journal-title":"The Lancet Neurology"},{"issue":"8","key":"10.1016\/j.clinbiochem.2026.111093_b0515","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1038\/s41591-023-02449-7","article-title":"Clinical effects of lewy body pathology in cognitively impaired individuals","volume":"29","author":"Quadalti","year":"2023","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.clinbiochem.2026.111093_b0520","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/s41591-023-02450-0","article-title":"Cognitive effects of lewy body pathology in clinically unimpaired individuals","volume":"29","author":"Palmqvist","year":"2023","journal-title":"Nat. Med."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912026000214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912026000214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:10:09Z","timestamp":1773277809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912026000214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":104,"alternative-id":["S0009912026000214"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2026.111093","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b1-Synuclein seed amplification assay methodology and performance in Parkinson\u2019s disease, lewy body dementia, and multiple system atrophy: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2026.111093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists.","name":"copyright","label":"Copyright"}],"article-number":"111093"}}